Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igf1rtm1Jcbr mutation
(0 available);
any
Igf1r mutation
(86 available)
Ndor1Tg(UBC-cre/ERT2)1Ejb mutation
(6 available);
any
Ndor1 mutation
(32 available)
|
|
|
immune system
|
• mice challenged with house dust mite extract show improved lung function, attenuated airway hyperresponsiveness and mucus secretion, decrease in blood and bronchioalveolar lavage fluid eosinophils, a decrease in lung IL13 levels and collagen levels, decrease in smooth muscle thickness and depletion of goblet cell metaplasia compared to controls
|
mortality/aging
|
• tamoxifen treated mice treated with bleomycin to induce lung damage at 6 weeks of age show increased survival (79%) compared to controls (33%)
|
homeostasis/metabolism
respiratory system
|
• house dust mite-induced goblet cell hyperplasia is reduced in tamoxifen treated mice
|
|
• house dust mite-induced airway hyperresponsiveness is attenuated in tamoxifen treated mice
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igf1rtm1Jcbr mutation
(0 available);
any
Igf1r mutation
(86 available)
Ndor1Tg(UBC-cre/ERT2)1Ejb mutation
(6 available);
any
Ndor1 mutation
(32 available)
|
|
|
reproductive system
N |
• tamoxifen-treated mice exhibit normal testicular peritubular capsule and Leydig cells
|
|
• in tamoxifen-treated mice
|
|
• in mice treated with tamoxifen at 4 weeks
|
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
|
• seminiferous tubules in tamoxifen-treated mice are severely depleted of germ cells, including spermatogonia, spermatocytes, and spermatids
|
growth/size/body
|
• beginning after a week tamoxifen treatment starting at 4 weeks
|
|
• in mice treated with tamoxifen at 4 weeks
|
respiratory system
|
• distal bronchiolar epithelium in tamoxifen-treated mice is flatter with frequent interruptions and reduced cell height, proportion of cells with apical regions extruding into the bronchiolar lumen and nuclear density compared with control cells
|
|
• higher cellular density in tamoxifen-treated mice without a change in apoptosis rates
|
liver/biliary system
|
• 2-3 times higher in tamoxifen-treated mice without an affect in liver cellularity density or changes in apoptosis rates compared with wild-type mice
|
cellular
|
• in tamoxifen-treated mice
|
|
• seminiferous tubules in tamoxifen-treated mice are severely depleted of germ cells, including spermatogonia, spermatocytes, and spermatids
|
|
• 2-3 times higher in tamoxifen-treated mice without an affect in liver cellularity density or changes in apoptosis rates compared with wild-type mice
|
endocrine/exocrine glands
|
• in tamoxifen-treated mice
|
|
• in mice treated with tamoxifen at 4 weeks
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igf1rtm1Jcbr mutation
(0 available);
any
Igf1r mutation
(86 available)
Tg(Scgb1a1-cre)1Tauc mutation
(1 available)
|
|
|
homeostasis/metabolism
respiratory system
|
• smaller epithelial cell size in some terminal bronchioles
• lower proportion of Scgb1a1+ club cells in some terminal bronchioles
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igf1rtm1Jcbr mutation
(0 available);
any
Igf1r mutation
(86 available)
Tg(Nkx2-1-cre)2Sand mutation
(2 available)
|
|
|
growth/size/body
|
• mice are significantly overweight after puberty
|
homeostasis/metabolism
respiratory system
|
• smaller epithelial cell size in terminal bronchioles
• lower proportion of Scgb1a1+ club cells
• distal bronchiolar epithelium shows morphological changes including lower cell density, flatter cells with elongated nuclei and frequent interruptions of normal columnar organization
• however, no gross morphological alterations are seen in AEC2 cells or in the surrounding alveolar parenchyma
• proliferation of airway club cells is enhanced in terminal bronchial epithelium
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igf1rtm1Jcbr mutation
(0 available);
any
Igf1r mutation
(86 available)
Tg(Fabp4-cre)1Abel mutation
(0 available)
|
|
|
growth/size/body
|
• disproportionately increased at 24 weeks
|
|
• both males and females have gained more weight than controls by 10 weeks of age
• daily food intake normal
|
|
• significantly increased naso-anal length by 24-32 weeks of age
|
|
• disproportionately increased at 24 weeks
|
adipose tissue
|
• disproportionately increased in weight at 24 weeks
|
|
• increased number and diameter of adipocytes
|
|
• adipocyte abnormalities particularly evident in epigonadal fat
|
liver/biliary system
|
• disproportionately increased at 24 weeks
|
cardiovascular system
|
• disproportionately increased at 24 weeks
|
nervous system
|
• relative brain weight is significantly reduced at 24 weeks
|
homeostasis/metabolism